GNFTF
Genfit SA
Save
146.58M
Market cap
–
Current P/E
4.33x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Genfit S. A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis.
Similar securities
Based on sector and market capitalization
Report issue